Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation, as well as novel processes for preparing atorvastatin hemi-calcium forms I, VIII and IX

Details for Australian Patent Application No. 2003217653 (hide)

Owner TEVA PHARMACEUTICAL INDUSTRIES LTD.

Inventors Maidan-Hanoch, Dalia; Aronhime, Judith; Lifshitz-Liron, Revital; Hasson, Nir; Tessler, Limor

Agent King & Wood Mallesons of Level **** Street Melbourne VIC 3000 Australia

Pub. Number AU-A-2003217653

PCT Number PCT/US03/05384

PCT Pub. Number WO2003/070702

Priority 60/357,181 15.02.02 US; 60/425,325 12.11.02 US

Filing date 19 February 2003

Wipo publication date 9 September 2003

International Classifications

C07D 207/327 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/357,181 15.02.02 US; 60/425,325 12.11.02 US

9 October 2003 Application Open to Public Inspection

  Published as AU-A-2003217653

16 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003217654-METHOD OF TREATMENT OF HYPERTENSION USING SELECTIVE SEROTONIN RE-UPTAKE INHIBITORS (SSRIs)

2003217652-METHODS FOR CONTINUOUS PERFORMANCE TESTING